Revvity Signals
AI-Enabled Oversight of Clinical Trials
Pages
6
Time to read
8 mins
Publication
Language
English
Pages
6
Time to read
8 mins
Publication
Language
English
This white paper discusses the evolving landscape of clinical trial oversight, emphasizing the increasing complexity of trials and the need for integrated data management solutions. It outlines the challenges posed by fragmented workflows and manual processes, which can lead to operational and regulatory risks. The paper details how a unified technology solution can enhance clinical oversight by providing timely access to data, facilitating collaboration among stakeholders, and automating recordkeeping. It highlights the role of AI in improving analytical efficiency and detecting anomalies, thereby augmenting human decision-making rather than replacing it. Furthermore, the document explains the importance of purpose-built AI systems tailored for clinical workflows to ensure compliance with regulatory standards such as ICH E6(R3). By adopting AI-enabled oversight, organizations can streamline operations, reduce errors, and improve the integrity of trial data, ultimately supporting more timely and reliable decision-making in clinical research.